Dr. Chau is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
# SW430
Boston, MA 02215Phone+1 617-582-9833
Education & Training
University of Toronto Faculty of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2012 - 2019
Clinical Trials
- Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma Start of enrollment: 2017 Apr 25
Publications & Presentations
PubMed
- 12 citationsAssociation of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.Bin Xu, Kartik Viswanathan, Mahsa S Ahadi, Sara Ahmadi, Bayan Alzumaili
Thyroid. 2024-02-01 - Multidisciplinary Canadian consensus on the multimodal management of high-risk and radioactive iodine-refractory thyroid carcinoma.Shereen Ezzat, Jesse D Pasternak, Murali Rajaraman, Omar Abdel-Rahman, Andrée Boucher
Frontiers in Oncology. 2024-01-01 - 11 citationsNUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.Justine A Barletta, Steven D Gilday, Michelle Afkhami, Diana Bell, Theresa Bocklage
The American Journal of Surgical Pathology. 2022-12-01
Journal Articles
- Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Untreated Oral Cavity Squamous Cell CarcinomaGlenn J Hanna, Nicole Chau, Jochen Lorch, Robert I Haddad, JAMA Oncology
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
- Exome and Genome Sequencing of Nasopharynx Cancer Identifies NF-κB Pathway Activating MutationsSimion I Chiosea, Peter S Hammerman, Jennifer R Grandis, Nicole G Chau, Nature
Authored Content
- Neoadjuvant Nivolumab or Nivolumab plus Ipilimumab in Untreated Oral Cavity Squamous Cell CarcinomaAugust 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
